These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4853527)

  • 41. [An original Sida-project contributes to better drug control in Laos].
    Lennholm B
    Lakartidningen; 1996 Jun; 93(23):2214-8. PubMed ID: 8649106
    [No Abstract]   [Full Text] [Related]  

  • 42. Control listings ... narcotic and controlled drugs.
    Burnie CF
    Can Hosp; 1968 Mar; 45(3):39-45. PubMed ID: 5642767
    [No Abstract]   [Full Text] [Related]  

  • 43. [Status of side effects. 1. Background and current status].
    Lunde PK; Myhr K
    Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3223-4. PubMed ID: 2595688
    [No Abstract]   [Full Text] [Related]  

  • 44. [For a strict quality of active pharmaceutical ingredients].
    Astier A
    Ann Pharm Fr; 2008 Mar; 66(2):69-70. PubMed ID: 18570901
    [No Abstract]   [Full Text] [Related]  

  • 45. Microbial limits reviewed: the basis for unique Australian regulatory requirements for microbial quality of non-sterile pharmaceuticals.
    Tang S
    PDA J Pharm Sci Technol; 1998; 52(3):100-9. PubMed ID: 9691672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines from the International Conference on Harmonisation (ICH).
    Branch SK
    J Pharm Biomed Anal; 2005 Aug; 38(5):798-805. PubMed ID: 16076542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Private enterprise provides better and safer drugs].
    Monvall E
    Vardfacket; 1979 Mar; 3(6):17-8. PubMed ID: 258054
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: Controlled Substances Act of 1970.
    Myers MA
    Alaska Med; 1971 Jul; 13(3):71-3. PubMed ID: 5562701
    [No Abstract]   [Full Text] [Related]  

  • 49. Design and international harmonization of pharmacopoeial standards.
    Calam DH
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 51. India raises standards for traditional drugs.
    Sharma DC
    Lancet; 2000 Jul; 356(9225):231. PubMed ID: 10963211
    [No Abstract]   [Full Text] [Related]  

  • 52. [Separate drug control agencies united in a new, single organization].
    Forsberg B
    Lakartidningen; 1971 Apr; 68(15):1698-701. PubMed ID: 5577238
    [No Abstract]   [Full Text] [Related]  

  • 53. [Responsibility for adverse drug effects].
    Naess K
    Tidsskr Nor Laegeforen; 1971 Mar; 91(9):673-6. PubMed ID: 5576192
    [No Abstract]   [Full Text] [Related]  

  • 54. Panel discussion: Proposed changes in the USP--microbiological aspects. 3. Proposed microbial limit tests.
    Vera HD
    Bull Parenter Drug Assoc; 1969; 23(6):257-60. PubMed ID: 4901568
    [No Abstract]   [Full Text] [Related]  

  • 55. WHO Expert Committee on Specifications for Pharmaceutical Preparations. 22.
    World Health Organ Tech Rep Ser; 1969; 418():1-29. PubMed ID: 4980004
    [No Abstract]   [Full Text] [Related]  

  • 56. Forfeiture of the proceeds of drug-related crimes: a Swedish point of view.
    Riberdahl S; Vängby S
    Bull Narc; 1984; 36(4):51-9. PubMed ID: 6570700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Method of cylinders on plates for the determination of B 12 pharmaceutical preparations].
    de Oliveira-Dias G
    Rev Latinoam Microbiol; 1976; 18(1):43-5. PubMed ID: 1070773
    [No Abstract]   [Full Text] [Related]  

  • 58. [Validation of sterile pharmaceutical production. Considerations and experiences].
    Pongiluppi S
    Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520
    [No Abstract]   [Full Text] [Related]  

  • 59. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative advertising and medicine: changing of regulations].
    Chrétienne M
    Ann Pharm Fr; 1999 Jul; 57(4):350-4. PubMed ID: 10472708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.